gregory hinkle

[Cape Cod Times sports @sportsCCT]

@Athletics_FA

[gregory hinkle @gghink]

@nytopinion @ezraklein Clinton single-handedly turned the Dems from the party of New Bedford to the party of Nantucket.

[John Maraganore 🇺🇸🇬🇷🇺🇦 @JMaraganore]

At height of opioid crisis during my tenure as ⁦@IAmBiotech⁩ Chair, we developed industry principles to address crisis.

#1 was to rally industry innovation for non-addictive new Rx.

Today, we are one step closer to bringing this change for society! https://t.co/HfejSkT5Pm

[Laura Sepp-Lorenzino @LauraSepplore]

Two for two! Congrats to the team on our second @NEJM publication demonstrating the promise of #CRISPR!

[gregory hinkle @gghink]

@Alnylam Responsibility matters! Way to go Alnylam.

[gregory hinkle @gghink]

@NYTGames The bot was acting very oddly today. Saying it did the puzzle in 2 steps but showing a word procession of at least 3 guesses.

[The Boston Globe @BostonGlobe]

Biotech bound: For blue-collar apprentices, biomanufacturing can be a ticket to the middle class https://t.co/Y21O9O9X2z

[Ohad Hammer @ohadhammer]

$ALNY is probably one of the most productive R&D engines in biopharma's history. Expect 15 INDs (internal and partnered programs) in 2024-25.

[Alnylam Pharmaceuticals @Alnylam]

We love talking to students about #STEM, sparking interest in careers in #biotech! At @Nature's recent #CrackingtheCode23 @NatureConf hosted at @WPI, colleagues including our Chief DE&I Officer and former head of Regulatory, Sara Nochur met and spoke with hundreds of students from local high schools. We were thrilled by their interest and excitement and expect to see many of them become the next generation of biotech leaders!

[Alnylam Pharmaceuticals @Alnylam]

Proud to partner with @nature on their upcoming @natureconf focusing on the development of nucleic acid medicines. Excited for three days of discussing recent clinical successes, and current and upcoming challenges in the development of nucleic acid #medicines. #CrackingTheCode23

[Nature Conferences @NatureConf]

Our event exploring recent clinical and research developments of #NucleicAcid medicines is now open! Get your tix and submit abstracts at https://t.co/GdEM4NAtAQ

In partnership with @moderna_tx @Alnylam @WPI @UMassChan @Nature @natBME @NatureBiotech @NatImmunol @NatRevDrugDisc

[John Maraganore 🇺🇸🇬🇷🇺🇦 @JMaraganore]

Agree @VasantRJadhav! This is a remarkable clinical translation story!

1. ALN-HBV goes into clinic, shows LFT⬆️ not predicted in pre-clin studies

2. @Alnylam discovers hybridization-dependent off-targets, mediated by seed region miRNA-like effects

[gregory hinkle @gghink]

@thegridkid I loved the story puzzle. I told my non-daily-puzzle friends to give it a try.

[gregory hinkle @gghink]

@Freakonomics Not very

[gregory hinkle @gghink]

@JMaraganore @US_FDA A great day for patients

[Nature Conferences @NatureConf]

Deadline: Aug 21
Submit at: https://t.co/5dVI9Ny8dR
Topics:
#GenomeEditing #Transcriptomeediting #DNA #RNA #ASOs #siRNAs #GeneTherapies and more

@WPI @UMassChan @moderna_tx @Alnylam @NatureBiotech @natBME @NatImmunol @NatRevDrugDisc

[gregory hinkle @gghink]

@Freakonomics Microbreweries are ubiquitous. How did that happen? Worthy of your attention.

[gregory hinkle @gghink]

@TamarHaspel Cable TV

[Nature Biotechnology @NatureBiotech]

"Cracking the Code: The Dawn of Nucleic Acid Medicines" will bring together academics in basic and translational research and their peers in thriving biotechs and promising startups to foster dialog and to spearhead collaborations. Register now: https://t.co/1kafk65iWK

[John Maraganore 🇺🇸🇬🇷🇺🇦 @JMaraganore]

NIH funding makes papers, not drugs. Papers important, but can’t treat disease with them.

Risk capital investment makes drugs. Patients need drugs.